286.05MMarket Cap-2003P/E (TTM)
11.2700High9.4218Low862.13KVolume9.4400Open9.2800Pre Close9.21MTurnover3.38%Turnover RatioLossP/E (Static)25.91MShares14.748052wk High3.03P/B281.47MFloat Cap3.888052wk Low--Dividend TTM25.50MShs Float2352.0000Historical High--Div YieldTTM19.92%Amplitude3.8880Historical Low10.6810Avg Price1Lot Size
Inovio Pharmaceuticals Stock Forum
• BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
• Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
• Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...
No comment yet